UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR

Clinical trials for UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR trials appear

Sign up with your email to follow new studies for UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Race for a better treatment: two chemo regimens battle childhood brain cancer

Disease control Completed

This study aimed to find the best chemotherapy treatment for very young children (under 3 years old) with newly diagnosed, high-risk brain tumors. It directly compared two intense drug combinations, one with a drug called methotrexate and one without, to see which was more effect…

Matched conditions: UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR

Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR

Get alerted when new UNTREATED CHILDHOOD SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR trials appear

Race for a better treatment: two chemo regimens battle childhood brain cancer